Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

NCT03480321 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Intermittent Claudication

Interventions

DRUG: Cilostazol 100 mg
DRUG: PMR 150 mg
DRUG: PMR 200 mg

Sponsor

Genovate Biotechnology Co., Ltd.,